The DOI matches its Crossref record; 215 of the 290 references it cites were found in a registry or an index, and 72 are not checked yet; none of the 223 sources its claims cite is checked for support yet.
Epigenetics and cancer
Open accessAbstract
Epigenetic mechanisms act to change the accessibility of chromatin to transcriptional regulation locally and globally via modifications of the DNA and by modification or rearrangement of nucleosomes. Epigenetic gene regulation collaborates with genetic alterations in cancer development. This is evident from every aspect of tumor biology including cell growth and differentiation, cell cycle control, DNA repair, angiogenesis, migration, and evasion of host immunosurveillance. In contrast to genetic cancer causes, the possibility of reversing epigenetic codes may provide new targets for therapeutic intervention.
Checked 2026-10-06 · 72 references not checked yet
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
138 Not checked yet · 32 No basis given · 25 Own interpretation
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Epigenetic gene regulation collaborates with genetic alterations in cancer development.”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This is evident from every aspect of tumor biology including cell growth and differentiation, cell cycle control, DNA repair, angiogenesis, migration, and evasion of host immunosurveillance.”
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, other genes, such as cell cycle checkpoint genes and genes directly affected by exogenous stimuli such as growth factors or cell-cell contact, likely reside in a balanced state sensitive to dynamic adjustments in histone modifications, thereby allowing for rapid responses to specific stimuli.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Ser 10 phosphorylation also facilitates acetylation of Lys 9, thereby preventing the setting of repressive Lys 9 methylation marks (Rea et al. 2000).”
§ REVIEW Epigenetics and cancer > Epigenetic gene regulation
What the sources say
- Not checked yetcites Rea et al. 2000
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Not surprisingly therefore, epigenetic gene regulation is characterized overall by a high degree of integrity and stability.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Trimethylation of Lys 4 on histone H3 correlates with transcriptional activity (Santos-Rosa et al. 2002),”
§ REVIEW Epigenetics and cancer > Setting Trithorax imprints
What the sources say
- Not checked yetcites Santos-Rosa et al. 2002
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“EZH2 is overexpressed in many cancers (Varambally et al. 2002;Bracken et al. 2003;Kleer et al. 2003;Raaphorst et al. 2003)”
§ REVIEW Epigenetics and cancer > Setting Polycomb imprints
What the sources say
- Not checked yetcites Varambally et al. 2002
- Not checked yetcites Bracken et al. 2003
- Not checked yetcites Kleer et al. 2003
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“the expression level of EZH2 correlates with a poorer prognosis in both prostate (Varambally et al. 2002) and breast cancer (Kleer et al. 2003).”
§ REVIEW Epigenetics and cancer > Setting Polycomb imprints
What the sources say
- Not checked yetcites Varambally et al. 2002
- Not checked yetcites Kleer et al. 2003
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“and the other four human MLL homologs all reside in cancer-related loci.”
§ REVIEW Epigenetics and cancer > Setting Trithorax imprints
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“A second group of proteins, containing bromodomain and chromodomain modules, use the epigenetic marks on the histone tails as recognition landmarks to bind the chromatin and initiate downstream biological processes such as chromatin compaction, transcriptional regulation, or DNA repair (Fig. 2).”
§ REVIEW Epigenetics and cancer > Epigenetic gene regulation
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 70
- Probably not a substantial claim. 19
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In contrast to genetic cancer causes, the possibility of reversing epigenetic codes may provide new targets for therapeutic intervention.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Epigenetic changes that contribute to cancer can be reversed pharmacologically to produce therapeutic benefit.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Aside from the core histones, a variety of variant histone proteins exist and can be inserted into the nucleosome, possibly serving as landmarks for specific cellular functions (discussed following).”
§ REVIEW Epigenetics and cancer > Epigenetic gene regulation
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Surprisingly, although PRC2 complex members are directly controlled by the RB tumor-suppressor pathway, their expression levels do not appear to fluctuate in a cell cycle-dependent manner (Weinmann et al. 2001;Bracken et al. 2003).”
§ REVIEW Epigenetics and cancer > Setting Polycomb imprints
What the sources say
- Not checked yetcites Weinmann et al. 2001
- Not checked yetcites Bracken et al. 2003
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“This is exemplified in gene activation where phosphorylation of histone H3 Ser 10 facilitates acetylation of Lys 14 and methylation of Lys 4, resulting in an open chromatin conformation (Cheung et al. 2000;Lo et al. 2000).”
§ REVIEW Epigenetics and cancer > Epigenetic gene regulation
What the sources say
- Not checked yetcites Cheung et al. 2000
- Not checked yetcites Lo et al. 2000
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The pattern of histone modifications signifies the status of the chromatin locally and has been coined the histone code (Strahl and Allis 2000).”
§ REVIEW Epigenetics and cancer > Epigenetic gene regulation
What the sources say
- Not checked yetcites Strahl and Allis 2000
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Epigenetic programming is crucial in mammalian development, and stable inheritance of epigenetic settings is essential for the maintenance of tissue-and cell-typespecific functions (Li 2002).”
What the sources say
- Not checked yetcites Li 2002
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These functions point to long-range mechanisms of transcriptional repression and suggest that PRC2 activity may have global consequences to the cell, perhaps via more generally skewing the balance between specific histone methylation imprints.”
§ REVIEW Epigenetics and cancer > Setting Polycomb imprints
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“histone methylations can serve as anchorage points for both activator and repressor complexes and are thereby involved in conferring an epigenetic inheritance to the cell, carrying information related to differentiation commitment and function.”
§ REVIEW Epigenetics and cancer > Epigenetic gene regulation
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The nucleosome is made up of approximately two turns of DNA wrapped around a histone octamer built from two subunits of each histone, H2A, H2B, H3, and H4, respectively, In between core nucleosomes, the linker histone H1 attaches and facilitates further compaction (for a recent review, see Khorasanizadeh 2004).”
§ REVIEW Epigenetics and cancer > Epigenetic gene regulation
What the sources say
- Not checked yetcites Khorasanizadeh 2004
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Polycomb-group (PcG) proteins form transcriptional repressor modules that functionally can be divided into at least two distinct complexes: the initiation complex, Polycomb repression complex 2 (PRC2), the core of which in humans consists of EZH2, EED, and SUZ12; and the maintenance complex, PRC1, with the core proteins RNF2, HPC, EDR, and BMI1.”
§ REVIEW Epigenetics and cancer > Setting Polycomb imprints
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Al-though histone acetylation in general correlates with transcriptional activity,”
§ REVIEW Epigenetics and cancer > Epigenetic gene regulation
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
In the paper
“however, experimental overexpression of EZH2 results in target gene suppression only (Varambally et al. 2002), and hence does not sustain a notion of dominant negative effects.”
§ REVIEW Epigenetics and cancer > Setting Polycomb imprints
What the sources say
- Not checked yetcites Varambally et al. 2002
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“and the observed overexpression of EZH2 in cancers is likely causally related to tumorigenesis and not a mere consequence of deregulated RB-E2F functioning, as the EZH2 locus is amplified in several cancers (Bracken et al. 2003).”
§ REVIEW Epigenetics and cancer > Setting Polycomb imprints
What the sources say
- Not checked yetcites Bracken et al. 2003
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Although most histone modifications are reversible, no histone demethylase has been identified as yet, suggesting histone methylation to be involved in processes of long-term regulation.”
§ REVIEW Epigenetics and cancer > Epigenetic gene regulation
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The N-terminal tails of the histone proteins are protruding out from the nucleosomal core particles, and these tails serve as regulatory registers onto which epigenetic signals can be written.”
§ REVIEW Epigenetics and cancer > Epigenetic gene regulation
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Recent data have demonstrated that the SET domain present in EZH2 is responsible for methylation of Lys 9 and, more prominently, Lys 27 of histone H3 (Cao et al. 2002;Czermin et al. 2002;Kuzmichev et al. 2002;Muller et al. 2002) and Lys 26 on histone H1 (Kuzmichev et al. 2004).”
§ REVIEW Epigenetics and cancer > Setting Polycomb imprints
What the sources say
- Not checked yetcites Cao et al. 2002
- Not checked yetcites Czermin et al. 2002
- Not checked yetcites Kuzmichev et al. 2004
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Also DNA methylation affects histone modifications and vice versa, to make up a highly intricate epigenetic control mechanism, the impact of which we have only just begun to comprehend.”
§ REVIEW Epigenetics and cancer > Epigenetic gene regulation
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Members of both PcG and TrxG protein complexes harbor SET domains.”
§ REVIEW Epigenetics and cancer > Setting Polycomb imprints
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“The PRC2 complex is also required for X-chromosome inactivation (Plath et al. 2003;Silva et al. 2003) and for correct imprinting of autosomal loci (Wang et al. 2001b).”
§ REVIEW Epigenetics and cancer > Setting Polycomb imprints
What the sources say
- Not checked yetcites Plath et al. 2003
- Not checked yetcites Silva et al. 2003
- Not checked yetcites Wang et al. 2001b
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Covalent modification of histones includes acetylation of lysines, methylation of lysines and arginines, phosphorylations of serines and threonines, ADP-ribosylation of glutamic acids, and ubiquitination and sumolyation of lysine residues (Fig. 1).”
§ REVIEW Epigenetics and cancer > Epigenetic gene regulation
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Histone proteins can be mono-, di-, or trimethylated at the amino group of lysine residues and either mono-or dimethylated at arginine residues.”
§ REVIEW Epigenetics and cancer > Histone modification: setting the mark
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This, however, remains to be confirmed in mouse models.”
§ REVIEW Epigenetics and cancer > Setting Polycomb imprints
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“SMYD3 was found to interact with the RNA polymerase II complex and activate target genes via methylation of histone H3 Lys 4.”
§ REVIEW Epigenetics and cancer > Setting Trithorax imprints
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Evi1 was characterized in the mouse as a cancer-related retroviral integration site in myeloid leukemia (Morishita et al. 1988), and EVI1 was subsequently identified as a translocation breakpoint in hu-mans (Morishita et al. 1992).”
§ REVIEW Epigenetics and cancer > Setting Trithorax imprints
What the sources say
- Not checked yetcites Morishita et al. 1988
- Not checked yetcites Morishita et al. 1992
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Mll heterozygous mice do not appear tumor prone, making haploinsufficiency a less likely cause of leukemogenesis (Corral et al. 1996).”
§ REVIEW Epigenetics and cancer > Setting Trithorax imprints
What the sources say
- Not checked yetcites Corral et al. 1996
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Whereas Suv39h deficiency in the mouse predominantly was found to affect heterochromatin stability, the Suv39h methyltransferases associate with numerous proteins involved in cell cycle regulation including pRB (Nielsen et al. 2001;Vandel et al. 2001), PcG-proteins (Sewalt et al. 2002), and SMADs (Frontelo et al. 2004).”
§ REVIEW Epigenetics and cancer > Setting Trithorax imprints
What the sources say
- Not checked yetcites Nielsen et al. 2001
- Not checked yetcites Vandel et al. 2001
- Not checked yetcites Sewalt et al. 2002
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“SUV39H1 is the mammalian homolog of the Drosophila position effect variegation modifier Su(var)3-9 and was the first SET domain protein to be recognized as a histone methyl transferase (Rea et al. 2000).”
§ REVIEW Epigenetics and cancer > Setting Trithorax imprints
What the sources say
- Not checked yetcites Rea et al. 2000
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The Ash1-specific methylation imprint was found to displace HP1 and PcG proteins, which are normally bound to repressed genes, and instead facilitates the binding of the Brahma chromatin remodeling complex (Beisel et al. 2002).”
§ REVIEW Epigenetics and cancer > Setting Trithorax imprints
What the sources say
- Not checked yetcites Beisel et al. 2002
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This suggests a functional redundancy between different epigenetic gene repression mechanisms, which may serve to explain why loss of Suv39h-mediated repression does not have an even stronger phenotype.”
§ REVIEW Epigenetics and cancer > Setting Trithorax imprints
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Intriguingly, all fusion proteins retain the N-terminal part of MLL1, whereas the C-terminal part encoding the SET domain is lost.”
§ REVIEW Epigenetics and cancer > Setting Trithorax imprints
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In accordance with a tumor-suppressive function of RIZ1, ectopic expression in cancer cell lines results in cell cycle arrest and/or apoptosis (He et al. 1998;Jiang et al. 1999).”
§ REVIEW Epigenetics and cancer > Setting Trithorax imprints
What the sources say
- Not checked yetcites He et al. 1998
- Not checked yetcites Jiang et al. 1999
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“RIZ1, originally isolated from its interaction with the RB tumor suppressor protein (Buyse et al. 1995), was the first SET domain protein demonstrated to be a tumor suppressor (Steele-Perkins et al. 2001).”
§ REVIEW Epigenetics and cancer > Setting Trithorax imprints
What the sources say
- Not checked yetcites Buyse et al. 1995
- Not checked yetcites Steele-Perkins et al. 2001
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Mice deficient for the two Suv39 homologs display chromosomal instability and are prone to develop B-cell lymphomas resembling human non-Hodgkin lymphomas, albeit with long latency (Peters et al. 2001).”
§ REVIEW Epigenetics and cancer > Setting Trithorax imprints
What the sources say
- Not checked yetcites Peters et al. 2001
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In embryonic stem (ES) cells lacking both Suv39 homologs the pericentromeric heterochromatin is devoid of the characteristic trimethylation of histone H3, Lys 9. Instead, an alternative methylation imprint consisting of monomethylated Lys 9 and trimethylated Lys 27 has accumulated (Peters et al. 2003).”
§ REVIEW Epigenetics and cancer > Setting Trithorax imprints
What the sources say
- Not checked yetcites Peters et al. 2003
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The 5Ј MDS part of MDS-EVI1 contains a SET domain, and both retroviral integrations in the mouse and translocations in humans result in the selective overexpression of the EVI1 variant lacking a SET domain.”
§ REVIEW Epigenetics and cancer > Setting Trithorax imprints
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“SMYD3 was recently identified as a SET and MYND domain-containing protein overexpressed in colorectal carcinomas and hepatocellular carcinomas (Hamamoto et al. 2004).”
§ REVIEW Epigenetics and cancer > Setting Trithorax imprints
What the sources say
- Not checked yetcites Hamamoto et al. 2004
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Interestingly, only RIZ1 harbors a SET domain and appears to be the main target of inactivation in tumors (Huang 2002),”
§ REVIEW Epigenetics and cancer > Setting Trithorax imprints
What the sources say
- Not checked yetcites Huang 2002
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Whereas the oncogenic capacity of SMYD3 is yet to be confirmed in an in vivo model, overexpression of SMYD3 results in colony formation of NIH 3T3 cells.”
§ REVIEW Epigenetics and cancer > Setting Trithorax imprints
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The reduced histone H3 methylation resulting from loss of Suv39h caused a decrease in HP1 association to the telomeres and abnormal telomere elongation (Garcia- Cao et al. 2004).”
§ REVIEW Epigenetics and cancer > Setting Trithorax imprints
What the sources say
- Not checked yetcites Garcia-Cao et al. 2004
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“More than 40 specific translocations involving MLL1 have been described in human cancers to date (Ayton and Cleary 2001).”
§ REVIEW Epigenetics and cancer > Setting Trithorax imprints
What the sources say
- Not checked yetcites Ayton and Cleary 2001
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Interestingly, the MYND domain appears to confer sequence-specific binding to target genes.”
§ REVIEW Epigenetics and cancer > Setting Trithorax imprints
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
In the paper
“Likewise, RNAi-mediated knockdown of HDAC2 in colonic cancer cells resulted in cell death, indicating a role for HDAC2 in protecting cancer cells against apoptosis (Zhu et al. 2004a).”
§ REVIEW Epigenetics and cancer > Histone acetylation
What the sources say
- Not checked yetcites Zhu et al. 2004a
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Aside from histones, many transcriptional regulators, chromatin modifiers, and intracellular signal transducers are posttranslationally modified by acetylation.”
§ REVIEW Epigenetics and cancer > Histone acetylation
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Dnmt1 was shown to be necessary and sufficient for Fos-induced transformation of mouse fibroblast cells (Bakin and Curran 1999),”
§ REVIEW Epigenetics and cancer > DNA methylation
What the sources say
- Not checked yetcites Bakin and Curran 1999
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“On the other hand is the reliance of important tumorsuppressor mechanisms on HDAC function, as exemplified by the dependency of RB on HDAC1 for transcriptional repression of E2F target genes (Luo et al. 1998;Magnaghi-Jaulin et al. 1998;Robertson et al. 2000).”
§ REVIEW Epigenetics and cancer > Histone acetylation
What the sources say
- Not checked yetcites Luo et al. 1998
- Not checked yetcites Magnaghi-Jaulin et al. 1998
- Not checked yetcites Robertson et al. 2000
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“DNA methylation is tightly connected to cancer development and can act as a double-edged sword.”
§ REVIEW Epigenetics and cancer > DNA methylation
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“DNMT1 associates with the DNA replication fork and functions as a hemi-methylase responsible for maintaining correct methylation patterns on DNA replication.”
§ REVIEW Epigenetics and cancer > DNA methylation
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“All three methyltransferase enzymes have been found to be overexpressed in human tumors, although to moderate levels only (De Marzo et al. 1999;Robertson et al. 1999;Girault et al. 2003;Nagai et al. 2003).”
§ REVIEW Epigenetics and cancer > DNA methylation
What the sources say
- Not checked yetcites De Marzo et al. 1999
- Not checked yetcites Robertson et al. 1999
- Not checked yetcites Girault et al. 2003
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“CpG islands are most often associated with promoter regions and an estimated 60% of human genes contain a CpG island (Antequera and Bird 1993).”
§ REVIEW Epigenetics and cancer > DNA methylation
What the sources say
- Not checked yetcites Antequera and Bird 1993
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Germ-line mutations in DNMT3B underlies ICF syndrome, a rare disorder characterized by immunodeficiency, centromeric instability, and facial abnormalities (Hansen et al. 1999;Xu et al. 1999).”
§ REVIEW Epigenetics and cancer > DNA methylation
What the sources say
- Not checked yetcites Hansen et al. 1999
- Not checked yetcites Xu et al. 1999
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Hdac1-deficient mice are not viable and ES cells with homozygous Hdac1 deletion display proliferation defects correlating with increased levels of the cyclin-dependent kinase inhibitors p21 and p27 (Lagger et al. 2002), demonstrating the involvement of HDAC1 in cell cycle regulation.”
§ REVIEW Epigenetics and cancer > Histone acetylation
What the sources say
- Not checked yetcites Lagger et al. 2002
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Germ-line mutations in CBP causes the developmental disorder Rubenstein-Taybi syndrome, and these patients suffer an increased cancer risk (Petrij et al. 1995;Murata et al. 2001).”
§ REVIEW Epigenetics and cancer > Histone acetylation
What the sources say
- Not checked yetcites Petrij et al. 1995
- Not checked yetcites Murata et al. 2001
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Although no arginine-specific methyltransferases have been implicated in cancer development yet, several of these enzymes are involved in gene regulatory complexes important for cell cycle regulation.”
§ REVIEW Epigenetics and cancer > Arginine methyltransferases
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“PRMT5 was furthermore found to associate with and negatively regulate the cyclin E promoter (Fabbrizio et al. 2002).”
§ REVIEW Epigenetics and cancer > Arginine methyltransferases
What the sources say
- Not checked yetcites Fabbrizio et al. 2002
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Patterns of DNA methylation are laid out during early embryogenesis via the interplay of at least three active DNA methyltransferases, DNMT1, DNMT3A, and DNMT3B, and targeted deletions of these genes in the mouse have demonstrated that the enzymes are essential for normal development (Li et al. 1992;Okano et al. 1999).”
§ REVIEW Epigenetics and cancer > DNA methylation
What the sources say
- Not checked yetcites Li et al. 1992
- Not checked yetcites Okano et al. 1999
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Methylation at the C-5 position of cytosine residues present in CpG dinucleotides by DNMTs has evolved relatively late in evolution and is generally considered to facilitate static long-term gene silencing and to confer genome stability through repression of transposons and repetitive DNA elements (Yoder et al. 1997).”
§ REVIEW Epigenetics and cancer > DNA methylation
What the sources say
- Not checked yetcites Yoder et al. 1997
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Recently, Hdac2 was genetically linked to the Wnt pathway, as Hdac2 is overexpressed in tumors and tissues from mice lacking the adenomatosis polyposis coli (APC) tumor suppressor (Zhu et al. 2004a).”
§ REVIEW Epigenetics and cancer > Histone acetylation
What the sources say
- Not checked yetcites Zhu et al. 2004a
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The PRMT5 arginine methyltransferase can methylate both histone H3 and H4 in vitro and interacts directly with components of the SWI/SNF complex (Pal et al. 2003).”
§ REVIEW Epigenetics and cancer > Arginine methyltransferases
What the sources say
- Not checked yetcites Pal et al. 2003
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Interestingly, mouse embryo fibroblasts deficient for Dnmt3b are resistant to transformation by SV40 largeT and activated Ras oncogenes (Soejima et al. 2003), demonstrating that epigenetic and genetic mechanisms likely act in concert during cellular transformation.”
§ REVIEW Epigenetics and cancer > DNA methylation
What the sources say
- Not checked yetcites Soejima et al. 2003
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“On the one hand, oncogenesis is promoted by local hypermethylation of tumor-suppressor genes, whereas global genomic hypomethylation, on the other hand, affects oncogene expression and genomic stability (Jones and Baylin 2002).”
§ REVIEW Epigenetics and cancer > DNA methylation
What the sources say
- Not checked yetcites Jones and Baylin 2002
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Acetylation of histone proteins correlates with transcriptional activation and a dynamic equilibrium of histone acetylation is governed by the opposing actions of HATs and histone deacetylases (HDACs) (for recent reviews, see Marks et al. 2001;Yang 2004).”
§ REVIEW Epigenetics and cancer > Histone acetylation
What the sources say
- Not checked yetcites Marks et al. 2001
- Not checked yetcites Yang 2004
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“CpG dinucleotides are statistically underrepresented in the genome, likely because methylation of cytosine makes them more susceptible to deamination, but are locally enriched in shorter stretches of DNA (0.5 to several kilobases) known as CpG islands (Bird 2002).”
§ REVIEW Epigenetics and cancer > DNA methylation
What the sources say
- Not checked yetcites Bird 2002
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Both genes reside in regions frequently lost in tumors, and cancerspecific mutations abolishing the enzymatic activity of p300 have been identified (Muraoka et al. 1996;Gayther et al. 2000;Ozdag et al. 2002).”
§ REVIEW Epigenetics and cancer > Histone acetylation
What the sources say
- Not checked yetcites Muraoka et al. 1996
- Not checked yetcites Gayther et al. 2000
- Not checked yetcites Ozdag et al. 2002
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“the regulatory regions of many genes (including known tumor suppressors) contain islands of repetitive sequences, some of which have been shown to influence transcriptional regulation (Jordan et al. 2003;Kelly 2003).”
§ REVIEW Epigenetics and cancer > DNA methylation
What the sources say
- Not checked yetcites Jordan et al. 2003
- Not checked yetcites Kelly 2003
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Loss of imprinting of the IGF2 gene was recently suggested as a predictive marker for colorectal cancer (Cui et al. 2003).”
§ REVIEW Epigenetics and cancer > DNA methylation
What the sources say
- Not checked yetcites Cui et al. 2003
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“CTCF is involved in the regulation of imprinting, where it is required to protect against de novo methylation (Fedoriw et al. 2004;Lewis and Murrell 2004).”
§ REVIEW Epigenetics and cancer > DNA methylation
What the sources say
- Not checked yetcites Fedoriw et al. 2004
- Not checked yetcites Lewis and Murrell 2004
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Also, hypermethylation of tumor-suppressor genes may be an early event in cancer development (Waki et al. 2003;Lee et al. 2004;Suter et al. 2004), suggesting that epigenetic and mutational cancer causes may collaborate from an early time point in disease progression.”
§ REVIEW Epigenetics and cancer > DNA methylation
What the sources say
- Not checked yetcites Waki et al. 2003
- Not checked yetcites Lee et al. 2004
- Not checked yetcites Suter et al. 2004
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“it has been suggested that DNMTs may preferentially bind to damaged or mismatched DNA (James et al. 2003).”
§ REVIEW Epigenetics and cancer > DNA methylation
What the sources say
- Not checked yetcites James et al. 2003
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Epigenetic induction of a classical mutator phenotype via transcriptional inactivation of the DNA mismatch repair gene MLH1 has been proposed to account for microsatellite instability in colorectal cancers (Kane et al. 1997;Herman et al. 1998;Toyota et al. 1999a,b),”
§ REVIEW Epigenetics and cancer > DNA methylation
What the sources say
- Not checked yetcites Kane et al. 1997
- Not checked yetcites Herman et al. 1998
- Not checked yetcites Toyota et al. 1999a,b
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“In contrast to hypermethylation of tumor-suppressor genes, tumor cells globally display an overall hypomethylation of DNA (Feinberg and Vogelstein 1983a;Goelz et al. 1985) and hypomethylation was the first epigenetic mechanism to be linked to cancer development (Feinberg and Tycko 2004).”
§ REVIEW Epigenetics and cancer > DNA methylation
What the sources say
- Not checked yetcites Feinberg and Vogelstein 1983a
- Not checked yetcites Goelz et al. 1985
- Not checked yetcites Feinberg and Tycko 2004
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Global genomic demethylation appears to progress with age in a tissue-dependent manner (Richardson 2003) and may in part explain the higher incidence of cancer among the elderly.”
§ REVIEW Epigenetics and cancer > DNA methylation
What the sources say
- Not checked yetcites Richardson 2003
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Genomic hypomethylation may furthermore cause genomic instability, presumably because demethylation predisposes to DNA strand breakage and recombination within derepressed repetitive sequences (for review, see Ehrlich 2002).”
§ REVIEW Epigenetics and cancer > DNA methylation
What the sources say
- Not checked yetcites Ehrlich 2002
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“BRG1/BRM expression was found lost in 10% of primary lung tumors correlating with a poor prognostic outcome (Reisman et al. 2003).”
§ REVIEW Epigenetics and cancer > Messing around with nucleosomes
What the sources say
- Not checked yetcites Reisman et al. 2003
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Noncoding antisense RNA driving DNA methylation”
§ REVIEW Epigenetics and cancer > Conclusions
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“The H2A variant H2AX marks DNA double-strand breaks, and H2AX-deficient cells have increased genomic instability and impaired forma-tion of radiation-induced foci of DNA repair proteins such as BRCA1 (Bassing et al. 2002;Celeste et al. 2002).”
§ REVIEW Epigenetics and cancer > Variant histones
What the sources say
- Not checked yetcites Bassing et al. 2002
- Not checked yetcites Celeste et al. 2002
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“DNA methylation driving histone modification”
§ REVIEW Epigenetics and cancer > Conclusions
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“In both mammals and flies, HP1 acts in a dosage-dependent manner with heterozygotes displaying a partial loss of gene silencing and HP1 overexpression resulting in an increase in silencing (Eissenberg et al. 1992;Festenstein et al. 1999).”
§ REVIEW Epigenetics and cancer > HP1 proteins
What the sources say
- Not checked yetcites Eissenberg et al. 1992
- Not checked yetcites Festenstein et al. 1999
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Histone modification directing DNA methylation”
§ REVIEW Epigenetics and cancer > Conclusions
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
In the paper
“HP1␣ and HP1 localize to pericentric heterochromatin and minor sites within euchromatin, whereas HP1␥ localizes predominantly to euchromatic regions (Eissenberg and Elgin 2000).”
§ REVIEW Epigenetics and cancer > HP1 proteins
What the sources say
- Not checked yetcites Eissenberg and Elgin 2000
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“These studies place Bmi1, and thereby epigenetic gene regulation, central to the emerging concept of tumor stem cells, which aside from having escaped cellular growth control mechanisms such as the p53 and the pRB pathways, also have (re)instigated a stem cell-like transcription program that allows for continuous self-renewal (Pardal et al. 2003;Valk-Lingbeek et al. 2004).”
§ REVIEW Epigenetics and cancer > Polycomb proteins
What the sources say
- Not checked yetcites Pardal et al. 2003
- Not checked yetcites Valk-Lingbeek et al. 2004
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“CENP-A was recently found to be overexpressed and mislocalized in primary human colorectal tumors, suggesting a link between CENP-A deregulation and aneuploidy (Tomonaga et al. 2003).”
§ REVIEW Epigenetics and cancer > Variant histones
What the sources say
- Not checked yetcites Tomonaga et al. 2003
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“the expression of HP1␣ is reportedly down-regulated in invasive human breast cancer cells, and overexpression of HP1␣ results in diminished invasive potential (Kirschmann et al. 2000).”
§ REVIEW Epigenetics and cancer > HP1 proteins
What the sources say
- Not checked yetcites Kirschmann et al. 2000
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Loss of Suv39h in mice results in the displacement of HP1 proteins from pericentromeric heterochromatin, resulting in anaploidy and cancer (Peters et al. 2001).”
§ REVIEW Epigenetics and cancer > HP1 proteins
What the sources say
- Not checked yetcites Peters et al. 2001
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper relies on this without support.
Epigenetic changes that contribute to cancer can be reversed pharmacologically to produce therapeutic benefit.
“In contrast to genetic cancer causes, the possibility of reversing epigenetic codes may provide new targets for therapeutic intervention.”
The paper relies on this without support.
Understanding the molecular details of epigenetic cancer mechanisms will translate into new drug development strategies.
“Understanding the molecular details behind”
The paper relies on this without support.
Findings from model organisms and cell lines are informative about human cancer epigenetics.
“Mouse models have further validated a role for genomic hypomethylation in tumor formation”
The paper relies on this without support.
Epigenetic alterations observed in cancer cell lines and xenografts reflect primary human tumor biology.
“MBD2 knockdown in human cancer cell lines was found to suppress tumorigenesis in a mouse xenograft model”
The authors state this as an assumption.
Reversal of epigenetic silencing will reinstate cellular cancer defense mechanisms.
“The fundamental principle behind this type of epigenetic therapy is that reversal of epigenetic silencing will reinstate cellular cancer defense mechanisms”
The paper relies on this without support.
There is limited knowledge about possible adverse effects in patients.
“relatively little is known about potential side effects in patients”
The paper relies on this without support.
Not all epigenetic marks are known.
“not all epigenetic marks are known”
The paper relies on this without support.
Only few of the known epigenetic marks are understood in any detail.
“only few of the known ones are understood in any detail”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both chromatin remodelling and DNA methylation have been linked to tumorigenesis119,120.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [119]
Citations
Cites
2 retracted
Histone methylation by the Drosophila epigenetic transcriptional regulator Ash1
Beisel, C., Imhof, A., Greene, J., Kremmer, E., & Sauer, F. (2002) · Nature · doi:10.1038/nature01126 · Cited by 310
RetractedHairpin RNAs and Retrotransposon LTRs Effect RNAi and Chromatin-Based Gene Silencing
Schramke, V., & Allshire, R. C. (2003) · Science · doi:10.1126/science.1086870 · Cited by 307
RetractedBartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
DNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Prediction of Mammalian MicroRNA Targets
Lewis, B. P., Shih, I.-H., Jones-Rhoades, M. W., Bartel, D. P., & Burge, C. B. (2003) · Cell · doi:10.1016/s0092-8674(03)01018-3 · Cited by 5,199
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,096
Targeted mutation of the DNA methyltransferase gene results in embryonic lethality
Li, E., Bestor, T. H., & Jaenisch, R. (1992) · Cell · doi:10.1016/0092-8674(92)90611-f · Cited by 3,984
Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing
Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R. S., & Zhang, Y. (2002) · Science · doi:10.1126/science.1076997 · Cited by 3,775
Nan, X., Ng, H.-H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N., & Bird, A. (1998) · Nature · doi:10.1038/30764 · Cited by 3,440
Epigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain
Bannister, A. J., Zegerman, P., Partridge, J. F., Miska, E. A., Thomas, J. O., Allshire, R. C., & Kouzarides, T. (2001) · Nature · doi:10.1038/35065138 · Cited by 2,903
Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins
Lachner, M., O'Carroll, D., Rea, S., Mechtler, K., & Jenuwein, T. (2001) · Nature · doi:10.1038/35065132 · Cited by 2,868
Regulation of chromatin structure by site-specific histone H3 methyltransferases
Rea, S., Eisenhaber, F., O'Carroll, D., Strahl, B. D., Sun, Z.-W., Schmid, M., Opravil, S., Mechtler, K., Ponting, C. P., Allis, C. D., et al. (2000) · Nature · doi:10.1038/35020506 · Cited by 2,845 · cited 3×
“Ser 10 phosphorylation also facilitates acetylation of Lys 9, thereby preventing the setting of repressive Lys 9 methylation marks (Rea et al. 2000).”
BackgroundMethylated DNA and MeCP2 recruit histone deacetylase to repress transcription
Jones, P. L., Veenstra, G. J. C., Wade, P. A., Vermaak, D., Kass, S. U., Landsberger, N., Strouboulis, J., & Wolffe, A. P. (1998) · Nature Genetics · doi:10.1038/561 · Cited by 2,791
The polycomb group protein EZH2 is involved in progression of prostate cancer
Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717
CpG island methylator phenotype in colorectal cancer
Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., & Issa, J. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8681 · Cited by 2,562
Hypomethylation distinguishes genes of some human cancers from their normal counterparts
Feinberg, A. P., & Vogelstein, B. (1983) · Nature · doi:10.1038/301089a0 · Cited by 2,430
The history of cancer epigenetics
Feinberg, A. P., & Tycko, B. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1279 · Cited by 2,404
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 2×
“2001) and to associate with HP1 and SUV39H1 to direct histone methylation to target promoters (Nielsen et al. 2001; Narita et al. 2003).”
BackgroundActive Genes Are Tri-Methylated at K4 of Histone H3
Santos-Rosa, H., Schneider, R., Bannister, A. J., Sherriff, J., Bernstein, B. E., Emre, N. C. T., Schreiber, S. L., Mellor, J., & Kouzarides, T. (2002) · Nature · doi:10.1038/nature01080 · Cited by 2,138
Regulation of Heterochromatic Silencing and Histone H3 Lysine-9 Methylation by RNAi
Volpe, T. A., Kidner, C. A., Hall, I. M., Teng, G., Grewal, S. I. S., & Martienssen, R. A. (2002) · Science · doi:10.1126/science.1074973 · Cited by 2,055
A gene hypermethylation profile of human cancer.
Esteller, M., Corn, P. G., Baylin, S. B., & Herman, J. G. (2001) · PubMed · Cited by 2,032
Chromatin modification and epigenetic reprogramming in mammalian development
Li, E. (2002) · Nature Reviews Genetics · doi:10.1038/nrg887 · Cited by 1,900
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma
Herman, J. G., Umar, A., Polyák, K., Graff, J. R., Ahuja, N., Issa, J. J., Markowitz, S. D., Willson, J. K. V., Hamilton, S. R., Kinzler, K. W., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6870 · Cited by 1,887
Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells.
Park, I.-K., Qian, D., Kiel, M., Becker, M. W., Pihalja, M., Weissman, I. L., Morrison, S. J., & Clarke, M. F. (2003) · Nature · doi:10.1038/nature01587 · Cited by 1,871
Histone deacetylases and cancer: causes and therapies
Marks, P. A., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T., & Kelly, W. K. (2001) · Nature reviews. Cancer · doi:10.1038/35106079 · Cited by 1,866
Loss of the Suv39h Histone Methyltransferases Impairs Mammalian Heterochromatin and Genome Stability
Peters, A. H. F. M., O'Carroll, D., Scherthan, H., Mechtler, K., Sauer, S., Schöfer, C., Weipoltshammer, K., Pagani, M., Lachner, M., Kohlmaier, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00542-6 · Cited by 1,766
Structure and ligand of a histone acetyltransferase bromodomain
Dhalluin, C., Carlson, J. E., Zeng, L., He, C., Aggarwal, A. K., Zhou, M.-M., & Zhou, M.-M. (1999) · Nature · doi:10.1038/20974 · Cited by 1,732
Kleer, C. G., Cao, Q., Varambally, S., Shen, R., Ota, I., Tomlins, S. A., Ghosh, D., Sewalt, R. G. A. B., Otte, A. P., Hayes, D. F., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1933744100 · Cited by 1,649
Applying the principles of stem-cell biology to cancer
Pardal, R., Clarke, M. F., & Morrison, S. J. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1232 · Cited by 1,633
Kuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P., & Reinberg, D. (2002) · Genes & Development · doi:10.1101/gad.1035902 · Cited by 1,596
Jacobs, J. J. L., Kieboom, K., Marino, S., DePinho, R. A., & van Lohuizen, M. (1999) · Nature · doi:10.1038/16476 · Cited by 1,580
DNA methylation in cancer: too much, but also too little
Ehrlich, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205651 · Cited by 1,563
Cytosine methylation and the ecology of intragenomic parasites
Yoder, J. A., Walsh, C. P., & Bestor, T. H. (1997) · Trends in Genetics · doi:10.1016/s0168-9525(97)01181-5 · Cited by 1,562
A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome
Guy, J., Hendrich, B., Holmes, M., Martin, J. E., & Bird, A. (2001) · Nature Genetics · doi:10.1038/85899 · Cited by 1,558
Histone Methyltransferase Activity of a Drosophila Polycomb Group Repressor Complex
Müller, J., Hart, C. M., Francis, N. J., Vargas, M. L., Sengupta, A. K., Wild, B., Miller, E., O’Connor, M. B., Kingston, R. E., & Simon, J. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00976-5 · Cited by 1,553
Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer
Versteege, I., Sévenet, N., Lange, J., Rousseau-Merck, M.-F., Ambros, P. F., Handgretinger, R., Aurias, A., & Delattre, O. (1998) · Nature · doi:10.1038/28212 · Cited by 1,552
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.
Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D. S., Gnarra, J. R., & Linehan, W. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9700 · Cited by 1,537
Czermin, B., Melfi, R., McCabe, D., Seitz, V., Imhof, A., & Pirrotta, V. (2002) · Cell · doi:10.1016/s0092-8674(02)00975-3 · Cited by 1,536
Induction of tumors in mice by genomic hypomethylation
Gaudet, F., Hodgson, J. G., Eden, A., Jackson-Grusby, L., Dausman, J., Gray, J. W., Leonhardt, H., & Jaenisch, R. (2003) · Science · doi:10.1126/science.1083558 · Cited by 1,499 · cited 1×
“…stem cells deficient for the Dnmt1 maintenance methyltransferase display an increased frequency of chromosomal rearrangements (Chen et al. 1998), and mice carrying a hypomorph Dnmt1 allele develop aggressive lymphomas displaying a high frequency of genomic rearrangements (Gaudet et al. 2003).”
BackgroundKane, M., Loda, M. F., Gaida, G. M., Lipman, J., Mishra, R., Goldman, H., Jessup, J. M., & Kolodner, R. D. (1997) · PubMed · Cited by 1,476
Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells.
Lessard, J., & Sauvageau, G. (2003) · Nature · doi:10.1038/nature01572 · Cited by 1,452
MethyLight: a high-throughput assay to measure DNA methylation
Eads, C. A. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.8.e32 · Cited by 1,412
DNA Methylation-Related Chromatin Remodeling in Activity-Dependent Bdnf Gene Regulation
Martinowich, K., Hattori, D., Wu, H., Fouse, S., He, F., Hu, Y., Fan, G., & Sun, Y. E. (2003) · Science · doi:10.1126/science.1090842 · Cited by 1,405
Genomic Instability in Mice Lacking Histone H2AX
Celeste, A., Petersen, S., Romanienko, P. J., Fernandez-Capetillo, O., Chen, H. T., Sedelnikova, O. A., Reina-San-Martin, B., Coppola, V., Meffre, E., Difilippantonio, M. J., et al. (2002) · Science · doi:10.1126/science.1069398 · Cited by 1,385
Herman, J. G., Merlo, A. U., Mao, L., Lapidus, R. G., Issa, J. J., Davidson, N. E., Sidransky, D., & Baylin, S. B. (1995) · PubMed · Cited by 1,341
Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation
Molofsky, A. V., Pardal, R., Iwashita, T., Park, I.-K., Clarke, M. F., & Morrison, S. J. (2003) · Nature · doi:10.1038/nature02060 · Cited by 1,317
Tagami, H., Ray-Gallet, D., Almouzni, G., & Nakatani, Y. (2004) · Cell · doi:10.1016/s0092-8674(03)01064-x · Cited by 1,297
Lehnertz, B., Ueda, Y., Derijck, A. A. H. A., Braunschweig, U., Perez-Burgos, L., Kubicek, S., Chen, T., Li, E., Jenuwein, T., & Peters, A. H. F. M. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00432-9 · Cited by 1,289
Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice
Chen, R. Z., Akbarian, S., Tudor, M., & Jaenisch, R. (2001) · Nature Genetics · doi:10.1038/85906 · Cited by 1,275
Role of Histone H3 Lysine 27 Methylation in X Inactivation
Plath, K., Fang, J., Mlynarczyk‐Evans, S., Cao, R., Worringer, K. A., Wang, H., de la Cruz, C. C., Otte, A. P., Panning, B., & Zhang, Y. (2003) · Science · doi:10.1126/science.1084274 · Cited by 1,241
Derepression of BDNF Transcription Involves Calcium-Dependent Phosphorylation of MeCP2
Chen, W. G., Chang, Q., Lin, Y., Meissner, A., West, A. E., Griffith, E. C., Jaenisch, R., & Greenberg, M. E. (2003) · Science · doi:10.1126/science.1086446 · Cited by 1,232
Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP
Petrif, F., Giles, R. H., Dauwerse, H. G., Saris, J. J., Hennekam, R. C. M., Masuno, M., Tommerup, N., van Ommen, G.-J. B., Goodman, R. H., Peters, D. J. M., et al. (1995) · Nature · doi:10.1038/376348a0 · Cited by 1,217
Partitioning and Plasticity of Repressive Histone Methylation States in Mammalian Chromatin
Peters, A. H. F. M., Kubicek, S., Mechtler, K., O’Sullivan, R. J., Derijck, A. A. H. A., Perez-Burgos, L., Kohlmaier, A., Opravil, S., Tachibana, M., Shinkai, Y., et al. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00477-5 · Cited by 1,208
Xu, G., Bestor, T. H., Bourc’his, D., Hsieh, C., Tommerup, N., Bugge, M., Hultén, M. A., Qu, X., Russo, J. J., & Viégas-Pèquignot, E. (1999) · Nature · doi:10.1038/46052 · Cited by 1,204
EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer.
Bracken, A. P., Pasini, D., Capra, M., Prosperini, E., Colli, E., & Helin, K. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg542 · Cited by 1,196
The non-coding Air RNA is required for silencing autosomal imprinted genes
Sleutels, F., Zwart, R., & Barlow, D. P. (2002) · Nature · doi:10.1038/415810a · Cited by 1,096
MLL Targets SET Domain Methyltransferase Activity to Hox Gene Promoters
Milne, T. A., Briggs, S. D., Brock, H. W., Martin, M. E., Gibbs, D. Y., Allis, C. D., & Hess, J. L. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00741-4 · Cited by 1,071
Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARFPreprint
Jacobs, J. J. L., Scheijen, B., Voncken, J. W., Kieboom, K., Berns, A. J. M., & van Lohuizen, M. (1999) · Genes & Development · doi:10.1101/gad.13.20.2678 · Cited by 1,069
DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci
Rountree, M. R., Bachman, K. E., & Baylin, S. B. (2000) · Nature Genetics · doi:10.1038/77023 · Cited by 1,056
A histone H3 methyltransferase controls DNA methylation in Neurospora crassa
Tamaru, H., & Selker, E. U. (2001) · Nature · doi:10.1038/35104508 · Cited by 1,054
The Methyl-CpG-binding Protein MeCP2 Links DNA Methylation to Histone Methylation
Fuks, F., Hurd, P. J., Wolf, D., Nan, X., Bird, A. P., & Kouzarides, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210256200 · Cited by 1,026
Yao, T., Oh, S. P., Fuchs, M., Zhou, N.-D., Ch'ng, L.-E., Newsome, D., Bronson, R. T., Li, E., Livingston, D. M., & Eckner, R. (1998) · Cell · doi:10.1016/s0092-8674(00)81165-4 · Cited by 1,018
Number of CpG islands and genes in human and mouse.
Antequera, F., & Bird, A. P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11995 · Cited by 1,011
Vernalization requires epigenetic silencing of FLC by histone methylation
Bastow, R., Mylne, J. S., Lister, C., Lippman, Z. B., Martienssen, R. A., & Dean, C. (2004) · Nature · doi:10.1038/nature02269 · Cited by 998
DNA methyltransferase Dnmt1 associates with histone deacetylase activity
Fuks, F., Burgers, W. A., Brehm, A., Hughes‐Davies, L., & Kouzarides, T. (2000) · Nature Genetics · doi:10.1038/71750 · Cited by 988
Tamkun, J. W., Deuring, R., Scott, M. P., Kissinger, M., Pattatucci, A. M. L., Kaufman, T. C., & Kennison, J. A. (1992) · Cell · doi:10.1016/0092-8674(92)90191-e · Cited by 988
Rb Interacts with Histone Deacetylase to Repress Transcription
Luo, R. X., Postigo, A. A., & Dean, D. C. (1998) · Cell · doi:10.1016/s0092-8674(00)80940-x · Cited by 957
DNA hypomethylation leads to elevated mutation rates
Chen, R. Z., Pettersson, U., Beard, C., Jackson‐Grusby, L., & Jaenisch, R. (1998) · Nature · doi:10.1038/25779 · Cited by 950
Robertson, K. D., Ait-Si-Ali, S., Yokochi, T., Wade, P. A., Jones, P. L., & Wolffe, A. P. (2000) · Nature Genetics · doi:10.1038/77124 · Cited by 942
Rb targets histone H3 methylation and HP1 to promoters
Nielsen, S. J., Schneider, R., Bauer, U., Bannister, A. J., Morrison, A. J., O’Carroll, D., Firestein, R., Cleary, M. L., Jenuwein, T., Herrera, R. E., et al. (2001) · Nature · doi:10.1038/35087620 · Cited by 940
Tkachuk, D., Köhler, S., & Cleary, M. L. (1992) · Cell · doi:10.1016/0092-8674(92)90602-9 · Cited by 913
Retinoblastoma protein represses transcription by recruiting a histone deacetylase
Magnaghi-Jaulin, L., Groisman, R., Naguibneva, I., Robin, P., Lorain, S., Levillain, J. P., Troalen, F., Trouche, D., & Harel‐Bellan, A. (1998) · Nature · doi:10.1038/35410 · Cited by 906
Establishment and Maintenance of a Heterochromatin Domain
Hall, I. M., Shankaranarayana, G. D., Noma, K.-I., Ayoub, N., Cohen, A., & Grewal, S. I. S. (2002) · Science · doi:10.1126/science.1076466 · Cited by 895
Robertson, K. D., Uzvölgyi, É., Liang, G., Talmadge, C. B., Sümegi, J., Gonzales, F. A., & Jones, P. A. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.11.2291 · Cited by 867
Hypomethylation of DNA from Benign and Malignant Human Colon Neoplasms
Goelz, S. E., Vogelstein, B., Hamilton, S. R., & Feinberg, A. P. (1985) · Science · doi:10.1126/science.2579435 · Cited by 849
Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors.
Biegel, J. A., Zhou, J. Y., RORKE, L. B., Stenstrom, C., Wainwright, L. M., & Fogelgren, B. (1999) · PubMed · Cited by 836
A Brg1 Null Mutation in the Mouse Reveals Functional Differences among Mammalian SWI/SNF Complexes
Bultman, S. J., Gebuhr, T., Yee, D., LaMantia, C., Nicholson, J., Gilliam, A. C., Randazzo, F. M., METZGER, D., Chambon, P., Crabtree, G. R., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00127-1 · Cited by 824
Gu, Y., Nakamura, T., Alder, H., Prasad, R., Canaani, O. D., Cimino, G. G., Croce, C. M., & Canaani, E. (1992) · Cell · doi:10.1016/0092-8674(92)90603-a · Cited by 822
Coordinated histone modifications mediated by a CtBP co-repressor complex
Shi, Y. G., Sawada, J.-I., Sui, G., Affar, E. B., Whetstine, J. R., Lan, F., Ogawa, H., Luke, M. P.-S., Nakatani, Y., & Shi, Y. (2003) · Nature · doi:10.1038/nature01550 · Cited by 821
Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation
Wade, P. A., Gégonne, A., Jones, P. L., Ballestar, E., Aubry, F., & Wolffe, A. P. (1999) · Nature Genetics · doi:10.1038/12664 · Cited by 811
Wang, H., Huang, Z., Li, X., Feng, Q. F., Erdjument‐Bromage, H., Strahl, B. D., Briggs, S. D., Allis, C. D., Wong, J., Tempst, P., et al. (2001) · Science · doi:10.1126/science.1060781 · Cited by 806
Epigenetic Dynamics of Imprinted X Inactivation During Early Mouse Development
Okamoto, I., Otte, A. P., Allis, C. D., Reinberg, D., & Heard, É. (2003) · Science · doi:10.1126/science.1092727 · Cited by 804
Cheung, P., Tanner, K. G., Cheung, W. L., Sassone‐Corsi, P., Denu, J. M., & Allis, C. D. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80256-7 · Cited by 803
E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.
Graff, J. R., Herman, J. G., Lapidus, R. G., Chopra, H., Xu, R., Jarrard, D. F., Isaacs, W. B., Pitha, P. M., Davidson, N. E., & Baylin, S. B. (1995) · PubMed · Cited by 796
ATP-Dependent Nucleosome Remodeling
Becker, P. B., & Hörz, W. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135400 · Cited by 790
Croce, L. D., Raker, V. A., Corsaro, M., Fazi, F., Fanelli, M., Faretta, M., Fuks, F., Lo‐Coco, F., Kouzarides, T., Nervi, C., et al. (2002) · Science · doi:10.1126/science.1065173 · Cited by 786
A Complex with Chromatin Modifiers That Occupies E2F- and Myc-Responsive Genes in G 0 Cells
Ogawa, H., Ishiguro, K., Gaubatz, S., Livingston, D. M., & Nakatani, Y. (2002) · Science · doi:10.1126/science.1069861 · Cited by 785
Borrow, J., Stanton, V. P., Andresen, J. M., Becher, R., Behm, F. G., Chaganti, R. S. K., Civin, C. I., Distèche, C. M., Dubé, I. D., Frischauf, A. M., et al. (1996) · Nature Genetics · doi:10.1038/ng0996-33 · Cited by 775
Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus tagging
van Lohuizen, M., Verbeek, S. J., Scheljen, B., Wientjens, E., van der Guidon, H., & Berns, A. J. M. (1991) · Cell · doi:10.1016/0092-8674(91)90382-9 · Cited by 763
Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression
Lagger, G., O'Carroll, D., Rembold, M., Khier, H., Tischler, J., Weitzer, G., Schuettengruber, B., Hauser, C., Brunmeir, R., Jenuwein, T., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/21.11.2672 · Cited by 760
SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells
Hamamoto, R., Furukawa, Y., Morita, M., Iimura, Y., Pittella-Silva, F., Li, M., Yagyu, R., & Nakamura, Y. (2004) · Nature Cell Biology · doi:10.1038/ncb1151 · Cited by 752
Bromodomain: an acetyl‐lysine binding domain
Zeng, L., & Zhou, M. (2002) · FEBS Letters · doi:10.1016/s0014-5793(01)03309-9 · Cited by 751
Valk-Lingbeek, M. E., Bruggeman, S. W. M., & van Lohuizen, M. (2004) · Cell · doi:10.1016/j.cell.2004.08.005 · Cited by 743
The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome
Hansen, R. S., Wijmenga, C., Luo, P., Stanek, A. M., Canfield, T. K., Weemaes, C. M. R., & Gartler, S. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14412 · Cited by 743
Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk
Cui, H., Cruz-Correa, M. R., Giardiello, F. M., Hutcheon, D. F., Kafonek, D. R., Brandenburg, S. A., Wu, Y., He, X., Powe, N. R., & Feinberg, A. P. (2003) · Science · doi:10.1126/science.1080902 · Cited by 735
Nakamura, T., Mori, T., Tada, S., Krajewski, W. A., Rozovskaia, T., Wassell, R. P., DuBois, G. C., Mazo, A., Croce, C. M., & Canaani, E. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00740-2 · Cited by 717
Khorasanizadeh, S. (2004) · Cell · doi:10.1016/s0092-8674(04)00044-3 · Cited by 715
Maintenance of genomic methylation requires a SWI2/SNF2-like protein
Jeddeloh, J. A., Stokes, T. L., & Richards, E. J. (1999) · Nature Genetics · doi:10.1038/8803 · Cited by 705
Maison, C., Bailly, D., Peters, A. H. F. M., Quivy, J., Roche, D. M. J., Taddei, A., Lachner, M., Jenuwein, T., & Almouzni, G. (2002) · Nature Genetics · doi:10.1038/ng843 · Cited by 688
bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia
Hanada, M., Delia, D., Aiello, A., Stadtmauer, E. A., & Reed, J. (1993) · Blood · doi:10.1182/blood.v82.6.1820.1820 · Cited by 673
Iyer, N. G., Özdağ, H., & Caldas, C. (2004) · Oncogene · doi:10.1038/sj.onc.1207118 · Cited by 661
DNA damage-induced G2–M checkpoint activation by histone H2AX and 53BP1
Fernández-Capetillo, Ó., Chen, H. T., Celeste, A., Ward, I. M., Romanienko, P. J., Morales, J. C., Naka, K., Xia, Z., Camerini‐Otero, R. D., Motoyama, N., et al. (2002) · Nature Cell Biology · doi:10.1038/ncb884 · Cited by 657
Heterochromatic Silencing and HP1 Localization in Drosophila Are Dependent on the RNAi Machinery
Pal‐Bhadra, M., Leibovitch, B. A., Gandhi, S. G., Rao, M., Bhadra, U., Birchler, J. A., & Elgin, S. C. R. (2004) · Science · doi:10.1126/science.1092653 · Cited by 655
Silva, J., Mak, W., Zvetkova, I., Appanah, R., Nesterova, T. B., Webster, Z., Peters, A. H. F. M., Jenuwein, T., Otte, A. P., & Brockdorff, N. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00068-6 · Cited by 654
Meneghini, M. D., Wu, M. K. Y., & Madhani, H. D. (2003) · Cell · doi:10.1016/s0092-8674(03)00123-5 · Cited by 650
An epigenetic road map for histone lysine methylation
Lachner, M., O’Sullivan, R. J., & Jenuwein, T. (2003) · Journal of Cell Science · doi:10.1242/jcs.00493 · Cited by 641
Binary switches and modification cassettes in histone biology and beyond
Fischle, W., Wang, Y., & Allis, C. D. (2003) · Nature · doi:10.1038/nature02017 · Cited by 640
Whang, Y. E., Wu, X., Suzuki, H., Reiter, R. E., Tran, C., Vessella, R. L., SAID, J. W., Isaacs, W. B., & Sawyers, C. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5246 · Cited by 639
Reconstitution of a Core Chromatin Remodeling Complex from SWI/SNF Subunits
Phelan, M. L., Sif, S., Narlikar, G. J., & Kingston, R. E. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80315-9 · Cited by 629
The SWI/SNF complex — chromatin and cancer
Roberts, C. W. M., & Orkin, S. H. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1273 · Cited by 618
DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells
Robert, M., Morin, S., Beaulieu, N., Gauthier, F., Chute, I. C., Barsalou, A., & MacLeod, A. R. (2002) · Nature Genetics · doi:10.1038/ng1068 · Cited by 615
Mutations truncating the EP300 acetylase in human cancers
Gayther, S. A., Batley, S. J., Linger, L., Bannister, A. J., Thorpe, K. L., Chin, S., Daigo, Y., Russell, P. A., Wilson, A., Sowter, H., et al. (2000) · Nature Genetics · doi:10.1038/73536 · Cited by 588
Origin of a substantial fraction of human regulatory sequences from transposable elements
Jordan, I. K., Rogozin, I. B., Glazko, G. V., & Koonin, E. V. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(02)00006-9 · Cited by 577
Lo, W., Trievel, R. C., Rojas, J. R., Duggan, L. J., Hsu, J.-Y., Allis, C. D., Marmorstein, R., & Berger, S. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80257-9 · Cited by 573
H2AX Haploinsufficiency Modifies Genomic Stability and Tumor Susceptibility
Celeste, A., Difilippantonio, S., Difilippantonio, M. J., Fernández-Capetillo, Ó., Pilch, D. R., Sedelnikova, O. A., Eckhaus, M., Ried, T., Bonner, W. M., & Nussenzweig, A. (2003) · Cell · doi:10.1016/s0092-8674(03)00567-1 · Cited by 558
García‐Cao, M., O’Sullivan, R. J., Peters, A. H. F. M., Jenuwein, T., & Blasco, M. A. (2003) · Nature Genetics · doi:10.1038/ng1278 · Cited by 557
Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas
Leung, C., Lingbeek, M., Shakhova, O., Liu, J. K., Tanger, E., Saremaslani, P., van Lohuizen, M., & Marino, S. (2004) · Nature · doi:10.1038/nature02385 · Cited by 549
Tufarelli, C., Stanley, J. A. S., Garrick, D., Sharpe, J. A., Ayyub, H., Wood, W. G., & Higgs, D. R. (2003) · Nature Genetics · doi:10.1038/ng1157 · Cited by 547
The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.
Smet, C. D., Backer, O. D., Faraoni, I., Lurquin, C., Brasseur, F., & Boon, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7149 · Cited by 542
Esteller, M., Toyota, M., Sánchez‐Céspedes, M., Capellá, G., Peinado, M. A., Watkins, D. N., Issa, J. J., Sidransky, D., Baylin, S. B., & Herman, J. G. (2000) · PubMed · Cited by 542
The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases
Yang, X. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh252 · Cited by 538
Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX
Bassing, C. H., Chua, K. F., Sekiguchi, J., Suh, H., Whitlow, S. R., Fleming, J. C., Monroe, B., Ciccone, D. N., Yan, C. T., Vlasáková, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122228699 · Cited by 537
Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype.
Toyota, M., Ahuja, N., Suzuki, H., Itoh, F., Ohe-Toyota, M., Imai, K., Baylin, S. B., & Issa, J. J. (1999) · PubMed · Cited by 530
Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis
Zhu, P., Martin, E., Mengwasser, J., Schlag, P., Janssen, K., & Göttlicher, M. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00114-x · Cited by 529
van der Vlag, J., & Otte, A. P. (1999) · Nature Genetics · doi:10.1038/70602 · Cited by 527
Corral, J., Lavenir, I., Impey, H. L., Warren, A. J., Forster, A. M., Larson, T., Bell, S. E., McKenzie, A. N. J., King, G., & Rabbitts, T. H. (1996) · Cell · doi:10.1016/s0092-8674(00)81269-6 · Cited by 520
Small RNAs Correspond to Centromere Heterochromatic Repeats
Reinhart, B. J., & Bartel, D. P. (2002) · Science · doi:10.1126/science.1077183 · Cited by 519
Hypomethylation of ras oncogenes in primary human cancers
Feinberg, A. P., & Vogelstein, B. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(83)80115-6 · Cited by 509
Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins
Ayton, P. M., & Cleary, M. L. (2001) · Oncogene · doi:10.1038/sj.onc.1204639 · Cited by 503
Bassing, C. H., Suh, H., Ferguson, D. O., Chua, K. F., Manis, J. P., Eckersdorff, M., Gleason, M., Bronson, R. T., Lee, C., & Alt, F. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00566-x · Cited by 497
Chromosome translocations in multiple myeloma
Bergsagel, P. L., & Kuehl, W. M. (2001) · Oncogene · doi:10.1038/sj.onc.1204641 · Cited by 478
Germline epimutation of MLH1 in individuals with multiple cancers
Suter, C. M., Martin, D. I. K., & Ward, R. L. (2004) · Nature Genetics · doi:10.1038/ng1342 · Cited by 475
Xist RNA and the Mechanism of X Chromosome Inactivation
Plath, K., Mlynarczyk‐Evans, S., Nusinow, D. A., & Panning, B. (2002) · Annual Review of Genetics · doi:10.1146/annurev.genet.36.042902.092433 · Cited by 468
A trithorax–like gene is interrupted by chromosome 11q23 translocations in acute leukaemias
Djabali, M., Selleri, L., Parry, P. J., Bower, M., Young, B. D., & Evans, G. A. (1992) · Nature Genetics · doi:10.1038/ng1092-113 · Cited by 468
Different Ezh2-Containing Complexes Target Methylation of Histone H1 or Nucleosomal Histone H3
Kuzmichev, A., Jenuwein, T., Tempst, P., & Reinberg, D. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00185-6 · Cited by 467
The HP1 protein family: getting a grip on chromatin
Eissenberg, J. C., & Elgin, S. C. R. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00058-7 · Cited by 461
Bachman, K. E., Rountree, M. R., & Baylin, S. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104661200 · Cited by 447
Constitutional Mutations of the hSNF5/INI1 Gene Predispose to a Variety of Cancers
Sévenet, N., Sheridan, E., Amram, D., Schneider, P., Handgretinger, R., & Delattre, O. (1999) · The American Journal of Human Genetics · doi:10.1086/302639 · Cited by 447
Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer
Grady, W. M., Willis, J. E., Guilford, P., Dunbier, A. K., Toro, T. T., Lynch, H. T., Wiesner, G. L., Ferguson, K., Eng, C., Park, J., et al. (2000) · Nature Genetics · doi:10.1038/79120 · Cited by 446
Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBPPreprint
Kung, A. L., Rebel, V. I., Bronson, R. T., Ch'ng, L.-E., Sieff, C. A., Livingston, D. M., & Yao, T. (2000) · Genes & Development · doi:10.1101/gad.14.3.272 · Cited by 443
Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1
Itahana, K., Zou, Y., Itahana, Y., Martinez, J.-L., Beausejour, C., Jacobs, J. J. L., van Lohuizen, M., Band, V., Campisi, J., & Dimri, G. P. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.389-401.2003 · Cited by 438
Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9Preprint
Ayton, P. M., & Cleary, M. L. (2003) · Genes & Development · doi:10.1101/gad.1111603 · Cited by 438
Altered control of cellular proliferation in the absence of mammalian brahma (SNF2α)
Reyes, J. C., Barra, J., Muchardt, C., Camus, A., Babinet, C., & Yaniv, M. (1998) · The EMBO Journal · doi:10.1093/emboj/17.23.6979 · Cited by 433
Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice
Roberts, C. W. M., Galusha, S. A., McMenamin, M. E., Fletcher, C. D. �., & Orkin, S. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.250492697 · Cited by 430
Impact of aging on DNA methylation
Richardson, B. (2003) · Ageing Research Reviews · doi:10.1016/s1568-1637(03)00010-2 · Cited by 429
Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene
Bachman, K. E., Park, B. H., Rhee, I. P., Rajagopalan, H., Herman, J. G., Baylin, S. B., Kinzler, K. W., & Vogelstein, B. (2003) · Cancer Cell · doi:10.1016/s1535-6108(02)00234-9 · Cited by 419
A Transcriptional Switch Mediated by Cofactor Methylation
Xu, W., Chen, H.-W., Du, K., Asahara, H., Tini, M., Emerson, B. M., Montminy, M., & Evans, R. M. (2001) · Science · doi:10.1126/science.1065961 · Cited by 418
Klochendler‐Yeivin, A., Fiette, L., Barra, J., Muchardt, C., Babinet, C., & Yaniv, M. (2000) · EMBO Reports · doi:10.1093/embo-reports/kvd129 · Cited by 405
Morishita, K., Parker, D. S., Mucenski, M. L., Jenkins, N. A., Copeland, N. G., & Ihle, J. N. (1988) · Cell · doi:10.1016/s0092-8674(88)91175-0 · Cited by 404
Linking the epigenetic ‘language’ of covalent histone modifications to cancer
Hake, S. B., Xiao, A., & Allis, C. D. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601575 · Cited by 393
Whole-genome expression analysis of snf/swi mutants of Saccharomyces cerevisiae
Sudarsanam, P., Iyer, V. R., Brown, P. O., & Winston, F. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3364 · Cited by 389
Use of Chromatin Immunoprecipitation To Clone Novel E2F Target Promoters
Weinmann, A. S., Bartley, S. M., Zhang, T., Zhang, M. Q., & Farnham, P. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.20.6820-6832.2001 · Cited by 383
Lsh, a member of the SNF2 family, is required for genome-wide methylationPreprint
Dennis, K., Fan, T., Geiman, T. M., Yan, Q., & Muegge, K. (2001) · Genes & Development · doi:10.1101/gad.929101 · Cited by 381
Reisman, D., Sciarrotta, J., Wang, W., Funkhouser, W. K., & Weissman, B. E. (2003) · PubMed · Cited by 381
Pal‐Bhadra, M., Bhadra, U., & Birchler, J. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00440-9 · Cited by 380
The Drosophila Fab-7 Chromosomal Element Conveys Epigenetic Inheritance during Mitosis and Meiosis
Cavalli, G., & Paro, R. (1998) · Cell · doi:10.1016/s0092-8674(00)81181-2 · Cited by 367
BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines.
Wong, A. K., Shanahan, F., Chen, Y., Lian, L., Ha, P. C., Hendricks, K., Ghaffari, S. R., Iliev, D., Penn, B., Woodland, A.-M., et al. (2000) · PubMed · Cited by 364
Selective Recognition of Acetylated Histones by Bromodomain Proteins Visualized in Living Cells
Kanno, T., Kanno, Y., Siegel, R. M., Jang, M. K., Lenardo, M. J., & Ozato, K. (2004) · Molecular Cell · doi:10.1016/s1097-2765(03)00482-9 · Cited by 363
A systematic profile of DNA methylation in human cancer cell lines.
Paz, M. F., Fraga, M. F., Avila, S., Guo, M., Pollán, M., Herman, J. G., & Esteller, M. (2003) · PubMed · Cited by 363
Epigenomics: beyond CpG islands
Fazzari, M. J., & Greally, J. M. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1349 · Cited by 360
Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas.
Girault, I., Tozlu, S., Lidereau, R., & Bièche, I. (2003) · PubMed · Cited by 358
The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells.
Dimri, G. P., Martínez‐Guitarte, J., Jacobs, J. J. L., Keblusek, P., Itahana, K., van Lohuizen, M., Campisi, J., Wazer, D. E., & Band, V. (2002) · PubMed · Cited by 357
van Doorn-Khosrovani, S. B. V. W. (2002) · Blood · doi:10.1182/blood-2002-05-1459 · Cited by 352
Polycomb CBX7 has a unifying role in cellular lifespan.
Gil, J., Bernard, D., Martínez, D., & Beach, D. (2004) · Nature Cell Biology · doi:10.1038/ncb1077 · Cited by 341
Polycomb, Epigenomes, and Control of Cell Identity
Orlando, V. (2003) · Cell · doi:10.1016/s0092-8674(03)00157-0 · Cited by 341
Roberts, C. W. M., Leroux, M. M., Fleming, M. D., & Orkin, S. H. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00185-x · Cited by 338
Imprinted X inactivation maintained by a mouse Polycomb group gene
Wang, J., Mager, J., Chen, Y., Schneider, E., Cross, J. C., Nagy, A., & Magnuson, T. (2001) · Nature Genetics · doi:10.1038/ng574 · Cited by 338
Vernalization and epigenetics: how plants remember winter
Sung, S., & Amasino, R. M. (2004) · Current Opinion in Plant Biology · doi:10.1016/j.pbi.2003.11.010 · Cited by 326
Sobulo, O. M., Borrow, J., Tomek, R., Reshmi, S. C., Harden, A. M., Schlegelberger, B., Housman, D. E., Doggett, N. A., Rowley, J. D., & Zeleznik‐Le, N. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8732 · Cited by 321
Eissenberg, J. C., Morris, G. D., Reuter, G., & Hartnett, T. (1992) · Genetics · doi:10.1093/genetics/131.2.345 · Cited by 315
Polycomb complexes and silencing mechanisms
Lund, A. H., & van Lohuizen, M. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.03.010 · Cited by 314
Self-citationCrosstalk between CARM1 Methylation and CBP Acetylation on Histone H3
Daujat, S., Bauer, U., Shah, V., Turner, B. M., Berger, S. L., & Kouzarides, T. (2002) · Current Biology · doi:10.1016/s0960-9822(02)01387-8 · Cited by 314
CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene.
Ohtani‐Fujita, N., Fujita, T., Aoike, A., Osifchin, N. E., Robbins, P. D., & Sakai, T. (1993) · PubMed · Cited by 311
Histone variants, nucleosome assembly and epigenetic inheritance
Henikoff, S., Furuyama, T., & Ahmad, K. (2004) · Trends in Genetics · doi:10.1016/j.tig.2004.05.004 · Cited by 310
The 8;21 translocation in leukemogenesis
Peterson, L. F., & Zhang, D. (2004) · Oncogene · doi:10.1038/sj.onc.1207727 · Cited by 304
Vonlanthen, S., Heighway, J., Altermatt, H. J., Gugger, M., Каппелер, А., Borner, M., van Lohuizen, M., & Betticher, D. C. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1791 · Cited by 300
Angelov, D., Molla, A., Perche, P.-Y., Hans, F., Côté, J., Khochbin, S., Bouvet, P., & Dimitrov, S. I. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00100-x · Cited by 298
Overexpression and mistargeting of centromere protein-A in human primary colorectal cancer.
Tomonaga, T., Matsushita, K., Yamaguchi, S., 大橋, 建., Shimada, H., Ochiai, T., Yoda, K., & Nomura, F. (2003) · PubMed · Cited by 298
Transgenic RNAi Reveals Essential Function for CTCF in H19 Gene Imprinting
Fedoriw, A., Stein, P., Svoboda, P., Schultz, R. M., & Bartolomei, M. S. (2004) · Science · doi:10.1126/science.1090934 · Cited by 291
Tam, W., Ben‐Yehuda, D., & Hayward, W. S. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1490 · Cited by 287
Unsafe SETs: histone lysine methyltransferases and cancer
Schneider, R., Bannister, A. J., & Kouzarides, T. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02141-2 · Cited by 287
Tumour class prediction and discovery by microarray-based DNA methylation analysis
Adorján, P. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.5.e21 · Cited by 286
Modulation of Heterochromatin Protein 1 Dynamics in Primary Mammalian Cells
Festenstein, R., Pagakis, S. N., Hiragami, K., Lyon, D., Verreault, A., Sekkali, B., & Kioussis, D. (2003) · Science · doi:10.1126/science.1078694 · Cited by 283
p300 gene alterations in colorectal and gastric carcinomas.
Muraoka, M., Konishi, M., Kikuchi‐Yanoshita, R., Tanaka, K., Shitara, N., Chong, J., Iwama∥, T., & Miyaki, M. (1996) · PubMed · Cited by 282
Beà, S., Tort, F., Pinyol, M., Puig, X., Hernández, L., Hernandez, S. F., Fernández, P. L., van Lohuizen, M., Colomer, D., & Campo, E. (2001) · PubMed · Cited by 279
Morishita, K., Parganas, E., William, C. L., Whittaker, M. H., Drabkin, H. A., Oval, J., Taetle, R., Valentine, M. B., & Ihle, J. N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.3937 · Cited by 276
Klymenko, T., & Müller, J. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400111 · Cited by 270
Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia.
Myöhänen, S., Baylin, S. B., & Herman, J. G. (1998) · PubMed · Cited by 266
MLL and CREB Bind Cooperatively to the Nuclear Coactivator CREB-Binding Protein
Ernst, P., Wang, J., Huang, M., Goodman, R. H., & Korsmeyer, S. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.7.2249-2258.2001 · Cited by 256
Nakamura, M. (2001) · Carcinogenesis · doi:10.1093/carcin/22.10.1715 · Cited by 248
Nguyen, C. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.22.4598 · Cited by 246
Research works printed but not linked: 26
- 2001, Cancer Res., 61, 2409
- 1999, Cancer Res., 59, 74
- 1999, Cancer Res., 59, 3855
- 2002, Cancer Res., 62, 4736
- 2001, Cancer Res., 61, 8094
- 2000, Cancer Res., 60, 2368
- 2001, Cancer Res., 61, 3225
- 2003, Clin. Cancer Res., 9, 4415
- 1995, Cancer Res., 55, 5195
- 1998, Cancer Res., 58, 4238
- 1995, Cancer Res., 55, 4525
- 1997, Cancer Res., 57, 808
- 2003, Cancer Res., 63, 7619
- 2000, Cancer Res., 60, 3359
- 1996, Oncogene, 12, 1565
- 1998, Cancer Res., 58, 591
- 2002, Curr. Issues Mol. Biol., 4, 111
- 1993, Oncogene, 8, 1063
- 2003, Int. J. Oncol., 23, 1663
- 2003, Cancer Res., 63, 1114
- 2003, Cancer Res., 63, 560
- 2003, Cancer Res., 63, 3511
- 1999, Cancer Res., 59, 5438
- 2002, Cancer Res., 62, 2378
- 1999, Nat. Genet., 23, 62
- 2000, Cancer Res., 60, 6171
Cited by
Sorted by citations
Anticancer activities of histone deacetylase inhibitors
Bolden, J. E., Peart, M. J., & Johnstone, R. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2133 · Cited by 2,919
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Minucci, S., & Pelicci, P. G. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1779 · Cited by 2,234
Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?
Baylin, S. B., & Ohm, J. E. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1799 · Cited by 1,657
Cellular mechanisms of tumour suppression by the retinoblastoma gene
Burkhart, D. L., & Sage, J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2399 · Cited by 974
RNAi-mediated pathways in the nucleus
Matzke, M. A., & Birchler, J. A. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1500 · Cited by 858
Metadata
- Authors
- Lund, A. H., & van Lohuizen, M.
- Affiliations
- The Netherlands Cancer Institute (NL)
- ORCID
- Lund, Anders H.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2004-10-01
- Volume
- 18
- Issue
- 19
- Pages
- 2315-2335
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2136492640
- Semantic Scholar
- a8eac694f349babbcdf21346ba0dfed461fa4e4f
- Cited by
- 489
- References
- 290
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 5 · 2023: 9 · 2022: 9 · 2021: 15 · 2020: 11 · 2019: 13 · 2018: 11 · 2017: 19 · 2016: 23 · 2015: 22 · 2014: 25 · 2013: 34 · 2012: 23
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- epigenetics, cancer, chromatin accessibility, DNA methylation, histone modifications, transcriptional regulation, tumor biology, cell cycle regulation, DNA repair, angiogenesis, cell migration, immune evasion, epigenetic therapy
- MeSH terms
- Cell Cycle, Cell Differentiation, Cell Division, DNA Repair, Gene Expression Regulation, Humans, Neoplasms, Neovascularization, Pathologic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review